Sethi, Rupinder

Sethi, Rupinder was paid $5.63M by Medicaid between Jan 2018 and Nov 2024, across 77 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 32% of everything it billed.

33Billing provider infoSETHI, RUPINDER
ASHBURN, VA 20147

33aNPI1982617932assigned 08/14/2006

33bProvider typePediatrics Physician

28Total paid$5.63M

24GClaims181,880

24DCodes billed77

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other Pediatrics Physician providers in Virginia

Rank by total paid#22 of 817

Median peer was paid$29K

This provider vs. median192×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	23,997	$748K
2019	25,854	$658K
2020	28,563	$733K
2021	32,203	$906K
2022	28,151	$924K
2023	25,080	$936K
2024incomplete	18,032	$722K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	32%	32,480	24,524	$1.78M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	20%	13,646	11,516	$1.12M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	6.1%	4,792	4,432	$345K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	5.4%	4,287	3,966	$304K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	4.5%	3,260	3,029	$255K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	4.2%	3,613	3,196	$237K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	2.0%	3,549	3,172	$110K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	1.7%	3,359	3,004	$94K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	1.5%	3,420	3,122	$86K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	1.5%	258	236	$85K
90651		1.4%	1,694	1,568	$79K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	1.3%	5,836	5,198	$73K

65 more codes

96110	Developmental screening, with scoring and documentation, per standardized instrument	1.1%	8,398	$65K
90670		1.1%	2,610	$59K
99188		1.0%	3,226	$59K
99070		<1%	4,051	$54K
90698		<1%	3,063	$52K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	1,566	$50K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	639	$48K
99215	Doctor's office visit, returning patient (complex)	<1%	324	$39K
99204	Doctor's office visit, new patient (more involved)	<1%	368	$38K
90716		<1%	1,631	$36K
90680		<1%	2,118	$34K
90686		<1%	2,938	$31K
90620		<1%	764	$27K
90707		<1%	1,591	$26K
90619		<1%	439	$25K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	3,229	$25K
99401		<1%	1,464	$24K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	193	$23K
90677		<1%	360	$21K
99173		<1%	9,534	$21K
90734		<1%	617	$20K
99177		<1%	4,846	$19K
90633		<1%	1,490	$19K
90744		<1%	1,643	$18K
0001A		<1%	538	$18K
92551		<1%	1,955	$17K
90671		<1%	166	$17K
96127		<1%	3,556	$16K
87807		<1%	1,325	$16K
99000		<1%	6,358	$15K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	10,240	$14K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	305	$12K
87634		<1%	181	$10K
0002A		<1%	246	$9K
90461		<1%	5,410	$9K
87631		<1%	109	$8K
90672		<1%	508	$8K
90715		<1%	491	$7K
90688		<1%	520	$6K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	510	$5K
90696		<1%	403	$5K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	62	$5K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	5,513	$4K
96160		<1%	1,957	$4K
90656		<1%	249	$4K
86580		<1%	486	$3K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	220	$2K
69210		<1%	62	$2K
94664		<1%	209	$2K
99205	Prolong outpt/office vis	<1%	14	$2K
81002		<1%	548	$2K
90685		<1%	125	$1K
0003A		<1%	34	$1K
90473		<1%	481	$1K
99384		<1%	14	$786.08
99051		<1%	108	$761.78
99203	Doctor's office visit, new patient (routine)	<1%	14	$727.21
90660		<1%	40	$595.45
90472	Immunization administration, each additional vaccine (list separately)	<1%	582	$467.58
A7006	Administration set, with small volume filtered pneumatic nebulizer	<1%	122	$445.90
99495		<1%	14	$240.00
S8101	Holding chamber or spacer for use with an inhaler or nebulizer; with mask	<1%	14	$226.35
90700		<1%	15	$167.71
99072		<1%	864	$44.50
96161		<1%	16	$28.93

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.